Institut National de la Santé et de la Recherche Médicale U413, European Institute for Peptide Research (Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23), Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); EA4310, University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, Québec, Canada (S.B., A.F.); International Laboratory Samuel de Champlain (D.V., A.F.-M., S.B., M.B., D.B., O.W., A.F., H.V.); School of Biological Sciences, the University of Hong Kong, Pokfulam, Hong Kong (B.K.C.C.); Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences (H.H.), the Osaka-Hamamatsu Joint Research Center for Child Mental Development, Graduate School of Medicine (H.H.), and United Graduate School of Child Development, Osaka University, Kanazawa University, and Hamamatsu University School of Medicine, Osaka, Japan (H.H.); and Regional Platform for Cell Imaging (PRIMACEN), University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., L.G., H.V.)

Institut National de la Santé et de la Recherche Médicale U413, European Institute for Peptide Research (Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23), Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); EA4310, University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, Québec, Canada (S.B., A.F.); International Laboratory Samuel de Champlain (D.V., A.F.-M., S.B., M.B., D.B., O.W., A.F., H.V.); School of Biological Sciences, the University of Hong Kong, Pokfulam, Hong Kong (B.K.C.C.); Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences (H.H.), the Osaka-Hamamatsu Joint Research Center for Child Mental Development, Graduate School of Medicine (H.H.), and United Graduate School of Child Development, Osaka University, Kanazawa University, and Hamamatsu University School of Medicine, Osaka, Japan (H.H.); and Regional Platform for Cell Imaging (PRIMACEN), University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., L.G., H.V.)

Institut National de la Santé et de la Recherche Médicale U413, European Institute for Peptide Research (Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23), Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); EA4310, University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, Québec, Canada (S.B., A.F.); International Laboratory Samuel de Champlain (D.V., A.F.-M., S.B., M.B., D.B., O.W., A.F., H.V.); School of Biological Sciences, the University of Hong Kong, Pokfulam, Hong Kong (B.K.C.C.); Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences (H.H.), the Osaka-Hamamatsu Joint Research Center for Child Mental Development, Graduate School of Medicine (H.H.), and United Graduate School of Child Development, Osaka University, Kanazawa University, and Hamamatsu University School of Medicine, Osaka, Japan (H.H.); and Regional Platform for Cell Imaging (PRIMACEN), University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., L.G., H.V.)

Institut National de la Santé et de la Recherche Médicale U413, European Institute for Peptide Research (Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23), Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); EA4310, University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, Québec, Canada (S.B., A.F.); International Laboratory Samuel de Champlain (D.V., A.F.-M., S.B., M.B., D.B., O.W., A.F., H.V.); School of Biological Sciences, the University of Hong Kong, Pokfulam, Hong Kong (B.K.C.C.); Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences (H.H.), the Osaka-Hamamatsu Joint Research Center for Child Mental Development, Graduate School of Medicine (H.H.), and United Graduate School of Child Development, Osaka University, Kanazawa University, and Hamamatsu University School of Medicine, Osaka, Japan (H.H.); and Regional Platform for Cell Imaging (PRIMACEN), University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., L.G., H.V.)

Institut National de la Santé et de la Recherche Médicale U413, European Institute for Peptide Research (Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23), Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); EA4310, University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, Québec, Canada (S.B., A.F.); International Laboratory Samuel de Champlain (D.V., A.F.-M., S.B., M.B., D.B., O.W., A.F., H.V.); School of Biological Sciences, the University of Hong Kong, Pokfulam, Hong Kong (B.K.C.C.); Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences (H.H.), the Osaka-Hamamatsu Joint Research Center for Child Mental Development, Graduate School of Medicine (H.H.), and United Graduate School of Child Development, Osaka University, Kanazawa University, and Hamamatsu University School of Medicine, Osaka, Japan (H.H.); and Regional Platform for Cell Imaging (PRIMACEN), University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., L.G., H.V.)

Institut National de la Santé et de la Recherche Médicale U413, European Institute for Peptide Research (Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23), Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); EA4310, University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, Québec, Canada (S.B., A.F.); International Laboratory Samuel de Champlain (D.V., A.F.-M., S.B., M.B., D.B., O.W., A.F., H.V.); School of Biological Sciences, the University of Hong Kong, Pokfulam, Hong Kong (B.K.C.C.); Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences (H.H.), the Osaka-Hamamatsu Joint Research Center for Child Mental Development, Graduate School of Medicine (H.H.), and United Graduate School of Child Development, Osaka University, Kanazawa University, and Hamamatsu University School of Medicine, Osaka, Japan (H.H.); and Regional Platform for Cell Imaging (PRIMACEN), University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., L.G., H.V.)

Institut National de la Santé et de la Recherche Médicale U413, European Institute for Peptide Research (Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23), Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); EA4310, University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, Québec, Canada (S.B., A.F.); International Laboratory Samuel de Champlain (D.V., A.F.-M., S.B., M.B., D.B., O.W., A.F., H.V.); School of Biological Sciences, the University of Hong Kong, Pokfulam, Hong Kong (B.K.C.C.); Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences (H.H.), the Osaka-Hamamatsu Joint Research Center for Child Mental Development, Graduate School of Medicine (H.H.), and United Graduate School of Child Development, Osaka University, Kanazawa University, and Hamamatsu University School of Medicine, Osaka, Japan (H.H.); and Regional Platform for Cell Imaging (PRIMACEN), University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., L.G., H.V.)

Institut National de la Santé et de la Recherche Médicale U413, European Institute for Peptide Research (Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23), Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); EA4310, University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, Québec, Canada (S.B., A.F.); International Laboratory Samuel de Champlain (D.V., A.F.-M., S.B., M.B., D.B., O.W., A.F., H.V.); School of Biological Sciences, the University of Hong Kong, Pokfulam, Hong Kong (B.K.C.C.); Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences (H.H.), the Osaka-Hamamatsu Joint Research Center for Child Mental Development, Graduate School of Medicine (H.H.), and United Graduate School of Child Development, Osaka University, Kanazawa University, and Hamamatsu University School of Medicine, Osaka, Japan (H.H.); and Regional Platform for Cell Imaging (PRIMACEN), University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., L.G., H.V.)

Institut National de la Santé et de la Recherche Médicale U413, European Institute for Peptide Research (Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23), Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); EA4310, University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, Québec, Canada (S.B., A.F.); International Laboratory Samuel de Champlain (D.V., A.F.-M., S.B., M.B., D.B., O.W., A.F., H.V.); School of Biological Sciences, the University of Hong Kong, Pokfulam, Hong Kong (B.K.C.C.); Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences (H.H.), the Osaka-Hamamatsu Joint Research Center for Child Mental Development, Graduate School of Medicine (H.H.), and United Graduate School of Child Development, Osaka University, Kanazawa University, and Hamamatsu University School of Medicine, Osaka, Japan (H.H.); and Regional Platform for Cell Imaging (PRIMACEN), University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., L.G., H.V.)

Institut National de la Santé et de la Recherche Médicale U413, European Institute for Peptide Research (Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23), Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); EA4310, University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, Québec, Canada (S.B., A.F.); International Laboratory Samuel de Champlain (D.V., A.F.-M., S.B., M.B., D.B., O.W., A.F., H.V.); School of Biological Sciences, the University of Hong Kong, Pokfulam, Hong Kong (B.K.C.C.); Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences (H.H.), the Osaka-Hamamatsu Joint Research Center for Child Mental Development, Graduate School of Medicine (H.H.), and United Graduate School of Child Development, Osaka University, Kanazawa University, and Hamamatsu University School of Medicine, Osaka, Japan (H.H.); and Regional Platform for Cell Imaging (PRIMACEN), University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., L.G., H.V.)

Institut National de la Santé et de la Recherche Médicale U413, European Institute for Peptide Research (Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23), Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); EA4310, University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, Québec, Canada (S.B., A.F.); International Laboratory Samuel de Champlain (D.V., A.F.-M., S.B., M.B., D.B., O.W., A.F., H.V.); School of Biological Sciences, the University of Hong Kong, Pokfulam, Hong Kong (B.K.C.C.); Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences (H.H.), the Osaka-Hamamatsu Joint Research Center for Child Mental Development, Graduate School of Medicine (H.H.), and United Graduate School of Child Development, Osaka University, Kanazawa University, and Hamamatsu University School of Medicine, Osaka, Japan (H.H.); and Regional Platform for Cell Imaging (PRIMACEN), University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., L.G., H.V.)